Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 2 mg - capsule, hard - excipient ingredients: sodium stearylfumarate; povidone; maize starch; lactose monohydrate; gelatin; erythrosine; iron oxide yellow; sodium lauryl sulfate; titanium dioxide - gopten is indicated for the treatment of hypertension. data to support the usage of gopten in severe hypertension or renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wall motion index (wmi) less than or equal to 1.2],gopten is indicated for the treatment of hypertension. data to support the usage of gopten in renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wmi (wall motion index) less than or equal to 1.2]

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 0.5 mg - capsule, hard - excipient ingredients: titanium dioxide; povidone; erythrosine; gelatin; sodium stearylfumarate; sodium lauryl sulfate; maize starch; lactose monohydrate; iron oxide yellow - gopten is indicated for the treatment of hypertension. data to support the usage of gopten in severe hypertension or renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wall motion index (wmi) less than or equal to 1.2],gopten is indicated for the treatment of hypertension. data to support the usage of gopten in renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wmi (wall motion index) less than or equal to 1.2]

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 1 mg - capsule, hard - excipient ingredients: erythrosine; sodium lauryl sulfate; sodium stearylfumarate; povidone; iron oxide yellow; titanium dioxide; gelatin; lactose monohydrate; maize starch - gopten is indicated for the treatment of hypertension. data to support the usage of gopten in severe hypertension or renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wall motion index (wmi) less than or equal to 1.2],gopten is indicated for the treatment of hypertension. data to support the usage of gopten in renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wmi (wall motion index) less than or equal to 1.2]

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trandolapril, quantity: 2 mg - capsule, hard - excipient ingredients: dimeticone 350; microcrystalline cellulose; lactose monohydrate; pregelatinised maize starch; silicon dioxide; magnesium stearate; titanium dioxide; sunset yellow fcf; purified water; erythrosine; gelatin; sodium lauryl sulfate - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfunction post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - trandolapril - capsules hard - 2 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 4 mg - capsule - excipient ingredients: iron oxide black; gelatin; erythrosine; sodium stearylfumarate; iron oxide yellow; pregelatinised maize starch; titanium dioxide; lactose monohydrate; povidone; sodium lauryl sulfate - gopten is indicated for the treatment of hypertension. data to support the usage of gopten in severe hypertension or renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wall motion index (wmi) less than or equal to 1.2],gopten is indicated for the treatment of hypertension. data to support the usage of gopten in renovascular hypertension is, at present, not available. gopten is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35%) or wmi (wall motion index) less than or equal to 1.2]

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - trandolapril - capsules hard - 2 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - trandolapril - capsules hard - 2 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trandolapril, quantity: 4 mg - capsule, hard - excipient ingredients: dimeticone 350; microcrystalline cellulose; lactose monohydrate; pregelatinised maize starch; silicon dioxide; titanium dioxide; erythrosine; iron oxide red; iron oxide yellow; gelatin; iron oxide black - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfunction post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trandolapril, quantity: 1 mg - capsule, hard - excipient ingredients: dimeticone 350; microcrystalline cellulose; lactose monohydrate; pregelatinised maize starch; silicon dioxide; magnesium stearate; titanium dioxide; sunset yellow fcf; purified water; erythrosine; gelatin; sodium lauryl sulfate - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfunction post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).